Concepedia

Author

Michel Ségui

Sanofi (France)

Also Known As

M Ségui, M. Segui, M. Ségui, M. Álvarez Seguí, Michel Segui, Michel Ségui

9

Publications

566

Citations

7

H-Index

28

Concepts

All Affiliations

Sanofi (France)
MS

About

Michel Ségui is an author at Sanofi (France) specializing in inflammation, immunology, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

188

2

Allergy

3

3

188

3

Immunology

3

3

188

4

Cell Biology

2

2

125

5

Cellular Physiology

1

1

47

Michel Ségui

×

7

Publications

560

Citations

7

H-Index

YearCitations

Cannabinoids enhance human B‐cell growth at low nanomolar concentrations

Jean‐Marie Derocq, Michel Ségui, J Marchand,

FEBS Letters

1995

167

Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60

Jean‐Marie Derocq, Omar Jbilo, Monsif Bouaboula,

Journal of Biological Chemistry

2000

98

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor‐independent pathway in hematopoietic cell lines

Jean‐Marie Derocq, Monsif Bouaboula, J Marchand,

FEBS Letters

1998

78

Interleukin‐13 stimulates interleukin‐6 production by human keratinocytes

Jean‐Marie Derocq, Michel Ségui, C. Poinot-Chaze,

FEBS Letters

1994

63

Stimulation of peripheral cannabinoid receptor CB2 induces MCP‐1 and IL‐8 gene expression in human promyelocytic cell line HL60

Omar Jbilo, Jean‐Marie Derocq, Michel Ségui,

FEBS Letters

1999

57

In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.

Jean‐Marie Derocq, B. Bourrié, Michel Ségui,

Journal of Pharmacology and Experimental Therapeutics

1995

50

Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists

Jean‐Marie Derocq, Michel Ségui, C. Blazy,

FEBS Letters

1996

47

Page 1